Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of Moxidectin and Albendazole Compared to Ivermectin and Albendazole Co-administration in Adolescents Infected With Trichuris Trichiura: a Randomized Controlled Trial

NCT04700423 is registered in ClinicalTrials.gov with Jennifer Keiser as lead sponsor.

NCT NCT04700423
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04700423 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of Moxidectin and Albendazole Compared to Ivermectin and Albendazole Co-administration in Adolescents Infected With Trichuris Trichiura: a Randomized Controlled Trial
Lead sponsor
Jennifer Keiser
Phase
Phase 2/3
Overall status
Completed
Start date
March 1, 2021
Completion date
September 22, 2021
Enrollment
536 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

ascariasis, helminthes; infestation, intestinal, hookworm infections, trichuriasis